Pharmacogenomics in Clinical Practice
Clinicians are using pharmacogenomic testing to identify gene-drug interactions to guide precise patient therapies.
Read MorePosted by Elaine Sanchez Wilson | May 23, 2017 | Cerebrovascular, Molecular Diagnostics, Sexually Transmitted Diseases, Stroke |
Clinicians are using pharmacogenomic testing to identify gene-drug interactions to guide precise patient therapies.
Read MorePosted by Elaine Sanchez Wilson | May 22, 2017 | Breast, Cancer, Molecular Diagnostics |
The comprehensive assessment of a patient’s biological health is designed to measure immune health status and detect genetic mutations associated with cancer.
Read MorePosted by Elaine Sanchez Wilson | May 22, 2017 | Molecular Diagnostics |
The future of precision medicine depends on IT-enabled pharmacogenomic testing.
Read MorePosted by Steve Halasey | May 15, 2017 | Uncategorized |
CLP recently spoke with Eric B. Compton, MBA, chief operating officer at Hologic, Inc, to find out more about current and future policy initiatives that AdvaMedDx expects to advance.
Read MorePosted by Elaine Sanchez Wilson | May 9, 2017 | Molecular Diagnostics |
Under the terms of the agreement, SpeeDx will submit its ResistancePlus MG test to FDA upon successful validation of its use on the Applied Biosystems 7500 Fast Dx real-time polymerase chain reaction system.
Read More